| [June 12, 2014] |
 |
New Data about Inpatient Blood Sugar Management to Be Revealed at American Diabetes Association Meeting
SAN FRANCISCO --(Business Wire)--
Glytec, a clinical information technology company solely dedicated to
the mission of improving insulin management and glycemic control, today
announced that several abstracts featuring the company's eGlycemic
Management System™ (eGMS™) have been selected as poster presentations at
the American Diabetes Association (ADA) 74th Scientific Sessions. The 74th
Scientific Sessions, taking place from June 13th to June 17th
in San Francisco, are the premier venue for exchanging news and
showcasing innovation to the diabetes community.
During the conference, several posters will be presented that highlight
the success of improved glycemic management achieved by healthcare
providers utilizing Glytec's eGMS. The Glytec system's treatment
algorithms are designed to keep hospital patients from hyperglycemic or
hypoglycemic states after insulin treatment is ordered by the physician.
The following presentations will take place at the ADA 74th
Scientific Sessions:
-
Friday, June 13: Guillermo Umpierrez, MD, professor of medicine
in the division of endocrinology and metabolism at Emory University,
will deliver two presentations. The topic of the first presentation is
Inpatient Diabetes Management and the second is titled, "Randomized,
Controlled Trial of Intensive vs. Conservative Glucose Control in
Patients Undergoing Coronary Artery Bypass Graft Surgery."
-
Saturday, June 14: Carlos Mendez, MD, director of the diabetes
management center, at Albany VA Medical Center will present "Daily
Inpatient Glycemic Survey (DINGS): Report of a Process to Identify and
Assist in the Management of Hositalized Patients with Diabetes or
Hyperglycemia" during the General Poster Sessions.
-
Sunday, June 15: Posters titled, "Mountain
States Health Alliance Achieves Dramatic Improvements in Glycemic
Control with the Comprehensive Insulin-Dosing Software Platform by
Glytec" by Andrew Rhinehart, MD, medical director of Mountain
States Health Alliance and "Hospitalization
Costs, Resource Utilization, and Clinical Outcome in General Surgery
Patients with Hyperglycemia and Diabetes" by Dawn Smiley, MD,
investigator at Emory University School of Medicine will be exhibited.
Additionally, a related presentation by Dr. Smiley, "Hospitalization
Costs, Resource Utilization, and Clinical Outcome in Patients
Undergoing CABG Receiving Intensive vs. Conservative Glucose Control"
will take place during the Late Breaking Poster Session.
"Glytec's eGMS is an example of how advanced clinical information
technology is currently being employed to improve healthcare, from both
the patient and the operational perspectives," says Laurel Fuqua, RN,
Chief Clinical Innovation Officer at Glytec. "The sessions and exhibits
at this year's ADA Scientific Sessions can help healthcare providers
become more familiar with leading-edge research, products and services
that offer the promise of helping to alleviate pressures they now face
in terms of patient care, staffing and cost containment. There are
several presentations at this year's ADA meeting showcasing the
importance of inpatient glycemic management in improving the health
status of people with diabetes who are hospitalized. We are excited that
Glytec had many abstracts, posters and presentations accepted. And we're
proud of how they highlight research results using our inpatient
system," says Fuqua.
About Glytec:
Glytec is a clinical information technology company founded in 2006. It
is the only company to receive FDA clearance for computerized
intravenous, subcutaneous and pediatric insulin dosing algorithms:
Glucommander IV™ (2006), Glucommander SubQ™ (2010) and Glucommander
Pediatrics™ (2012). The Glucommander™ suite is cloud-based and augmented
by Glytec's GlucoMetrics™ and GlucoSurveillance™ analytics. Glytec's
eGlycemic Management System™ enables hospitals to significantly reduce
the frequency, risks and costs of hyperglycemia and hypoglycemia and
offer unprecedented quality to their diabetic and surgical patients. For
more information, please visit: http://www.glytecsystems.com/
[ Back To TMCnet.com's Homepage ]
|
